Loading stock data…
Accendra Health (ACH)
$1.10-0.11 (-9.09%)
After Hours$1.10+0.00 (+0.00%)· Last close Sep 8
Accendra Health, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Accendra Health, Inc. in the Healthcare sector is trading at $1.10 with a market capitalization of $237M. Wall Street consensus targets $1.51 (5 analysts), implying a +37.3% move over the next 12 months. The stock is currently near its 52-week low of $0.93, remaining 58.3% below its 200-day moving average. On fundamentals, Piotroski 2/9 flags weak fundamentals, Altman Z in the distress zone. The Whystock Score of 25/100 signals elevated caution as multiple indicators diverge.
Ecosystem Influences
Sell-side targets imply +37.3% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $627.78M↓ | $708.97M↑ | $697.26M↑ | $681.92M↑ | $673.88M |
| Gross Profit | $278.03M↓ | $323.26M↑ | $322.20M↓ | $324.60M↑ | $319.24M |
| Operating Income | $22.80M↓ | $51.76M↓ | $56.36M↓ | $56.75M↓ | $56.87M |
| Net Income | -$6.47M↑ | -$56.33M↑ | -$150.28M↑ | -$869.06M↓ | -$24.98M |
Peer Comparison
JNJUNHPFE
Fundamentals
Accendra Health, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States. It offers a range of products and services for in-home care and delivery for diabetes treatment; home respiratory therapy, includi...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$237.03M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
232.83%
Volume
Today's trading volume
786,826
Recent News
Accendra Health drops equity issuance plan as CEO succession process advances
Accendra Health (NYSE:ACH) has abandoned plans to establish an at-the-market equity issuance programme, citing recent market conditions, while also providing an updated timetable for appointing a successor to Chief Executive Christopher Pesicka. The proposed programme would have allowed Accendra to issue modest amounts of equity over time, with the proceeds intended to reduce debt.
ICU Medical (ICUI) Tops Q2 Earnings and Revenue Estimates
ICU Medical (ICUI) delivered earnings and revenue surprises of +24.08% and +2.33%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Accendra Health (ACH) is One of The 15 Best NYSE Penny Stocks According to Hedge Funds
Accendra Health Inc. (NYSE:ACH) is one of the 15 best NYSE penny stocks to buy according to hedge funds. On June 23, Accendra Health Inc. (NYSE:ACH) disclosed the final settlement of its previously disclosed offer, involving its outstanding 4.5% senior notes due 2029 and 6.625% senior notes due 2030. These have been exchanged with fresh […]
Is the Options Market Predicting a Spike in Accendra Health Stock?
Investors need to pay close attention to ACH stock based on the movements in the options market lately.
Alchemy Pay Adds Illinois License as U.S. Regulatory Coverage Reaches 18 States
Alchemy Pay (CRYPTO: $ACH) has added Illinois to its U.S. regulatory map, giving the fiat-crypto payments company a...